Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692938 · ClinicalTrials.gov registry record
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
A clinical trial of Age-related Macular Degeneration and Diabetic Retinopathy, sponsored by Optos.
- Completed
- Registry status
- 32
- Enrollment target
- 3
- Study locations
NCT01692938 is a study of Age-related Macular Degeneration and Diabetic Retinopathy that has completed, run by Optos. The registered enrollment target is 32 participants, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT01692938, a study of Age-related Macular Degeneration and Diabetic Retinopathy, has completed, sponsored by Optos.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
- 3
- Study locations
Study Summary
To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, and variability within a subject for a single operator-device configuration.
Conditions Studied
Study Locations (3)
Florida
- Retina Group of Florida - Fort Lauderdale
Maryland
- Johns Hopkins Unversity - Baltimore
Texas
- Valley Retina Institute - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2012-10 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01692938
The ClinicalTrials.gov registry entry for NCT01692938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,507-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (98% lower). The listed sponsor is Optos, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 0 interventions.
NCT01692938 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Maryland, Texas.
Frequently Asked Questions
What is clinical trial NCT01692938 about?
NCT01692938 is a clinical study titled "Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO". To conduct a precision study to assess the microperimetry function of the Spectral OCT/SLO. The study will assess variability across measurements taken by three different operator-device configuration across clinical sites, variability between subjects within a given operator-device configuration, a...
What is the current status of trial NCT01692938?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2012-10. Estimated completion is 2012-11.
What conditions does trial NCT01692938 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Geographic Atrophy, Macular Edema, Retinal Vein Occlusion.
Who is sponsoring clinical trial NCT01692938?
This trial is sponsored by Optos, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01692938 being conducted?
This trial has 3 study locations across Florida, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.